Patents by Inventor Gengshen Song

Gengshen Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTRAHEPATIC TARGETED CATIONIC LIPID COMPOUND WITH HIGH EFFICIENCY AND LOW TOXICITY AND ITS COMPOSITION
    Publication number: 20250109092
    Abstract: Provided in the present disclosure is a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof, which is an extrahepatic targeted cationic lipid compound with high efficiency and low toxicity. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic or prophylactic agent.
    Type: Application
    Filed: April 10, 2023
    Publication date: April 3, 2025
    Inventors: Gengshen SONG, Honglei ZHANG, Xichao CHEN, Huanyu WANG, Dawei HUANG, Xiaowen YU, Yangjian LIU, Yuqing LI, Rucan YAN, Lianyong QIAO, Xiaojuan LI, Xiaoling CHEN, Zhenlong SUN, Shuai WANG, Kai DONG, Jinyu ZHANG
  • CATIONIC LIPID COMPOUND, COMPOSITION CONTAINING SAME AND USE THEREOF
    Publication number: 20250082576
    Abstract: Provided in the present disclosure are a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic agent or prophylactic agent.
    Type: Application
    Filed: November 22, 2024
    Publication date: March 13, 2025
    Inventors: Gengshen Song, Huanyu Wang, Honglei Zhang, Xichao Chen, Xiaowen Yu, Dawei Huang
  • Cationic lipid compound, composition containing same and use thereof
    Patent number: 12171876
    Abstract: Provided in the present disclosure are a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic agent or prophylactic agent.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: December 24, 2024
    Assignee: HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD.
    Inventors: Gengshen Song, Huanyu Wang, Hognlei Zhang, Xichao Chen, Xiaowen Yu, Dawei Huang
  • CATIONIC LIPID COMPOUND, COMPOSITION CONTAINING SAME AND USE THEREOF
    Publication number: 20240252435
    Abstract: Provided in the present disclosure are a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt or stereoisomer thereof. Further provided are a composition containing the aforementioned compound, and the use thereof in the delivery of a therapeutic agent or prophylactic agent.
    Type: Application
    Filed: January 27, 2022
    Publication date: August 1, 2024
    Inventors: Gengshen Song, Huanyu Wang, Hognlei Zhang, Xichao Chen, Xiaowen Yu, Dawei Huang